Form 4 Filing for Replimune Group, Inc.

This Form 4 filing details transactions by Andrew Schwendenman, Chief Accounting Officer of Replimune Group, Inc. On April 1, 2026, Schwendenman acquired 36,667 shares of Common Stock (transaction code D) and was granted an Employee Stock Option to buy 55,000 shares of Common Stock. The stock option has a strike price of $7.61 and vests in stages, with 25% vesting on April 1, 2027, and the remainder vesting monthly thereafter. The RSUs granted will vest in stages, with 25% vesting on May 15, 2027, and the rest vesting in three annual installments until May 15, 2030. The filing was submitted late due to an administrative error. Post-transaction, Schwendenman holds 114,951 shares of Common Stock and 55,000 shares underlying the stock option.